Inventor · disambiguated record
Ning Zou
Also filed as: ZOU NING
17 granted patents·19 pending applications·106 citations·filing 2004–2024
94Inventor score
Top patents by PatentIndex Score
36 records- 0193US8148417B2Primary amines and derivatives thereof as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related theretoTEEGARDEN BRADLEY·Filed 2007·Granted Apr 3, 2012·21 cites·12 claims
- 0292US10668033B2Modulators of the prostacyclin (PGI2) receptor useful for the treatment of disorders related theretoARENA PHARM INC·Filed 2017·Granted Jun 2, 2020·4 cites·32 claims
- 0391US9328107B2Primary amines and derivatives thereof as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related theretoARENA PHARM INC·Filed 2014·Granted May 3, 2016·12 cites·34 claims
- 0491USRE45336EPrimary amines and derivatives thereof as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related theretoARENA PHARM INC·Filed 2007·Granted Jan 13, 2015·12 cites·22 claims
- 0591US8895776B2Modulators of the prostacyclin (PGI2) receptor useful for the treatment of disorders related theretoTRAN THUY-ANH·Filed 2009·Granted Nov 25, 2014·23 cites·98 claims
- 0691US8664258B2Primary amines and derivatives thereof as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related theretoTEEGARDEN BRADLEY·Filed 2012·Granted Mar 4, 2014·14 cites·25 claims
- 0789US9012478B2Pyrazolyl substituted carbonic acid derivatives as modulators of the prostacyclin (PGI2) receptor useful for the treatment of disorders related theretoARENA PHARM INC·Filed 2013·Granted Apr 21, 2015·4 cites·47 claims
- 0888US9663500B2Pyrazolyl substituted carbonic acid derivatives as modulators of the prostacyclin (PGI2) receptor useful for the treatment of disorders related theretoARENA PHARM INC·Filed 2015·Granted May 30, 2017·3 cites·13 claims
- 0986US2025009693A1Modulators of the prostacyclin (pgi2) receptor useful for the treatment of disorders related theretoARENA PHARM INC·Filed 2024·Application pending·0 cites
- 1085US11098034B2Pyrazolyl substituted carbonic acid derivatives as modulators of the prostacyclin (PGI2) receptor useful for the treatment of disorders related theretoARENA PHARM INC·Filed 2020·Granted Aug 24, 2021·1 cites·4 claims
- 1183US8940891B2Modulators of the prostacyclin (PGI2) receptor useful for the treatment of disorders related theretoTRAN THUY-ANH·Filed 2009·Granted Jan 27, 2015·6 cites·44 claims
- 1282US10689372B2Pyrazolyl substituted carbonic acid derivatives as modulators of the prostacyclin (PGI2) receptor useful for the treatment of disorders related theretoARENA PHARM INC·Filed 2018·Granted Jun 23, 2020·1 cites·21 claims
- 1382US10214518B2Pyrazolyl substituted carbonic acid derivatives as modulators of the prostacyclin (PGI2) receptor useful for the treatment of disorders related theretoARENA PHARM INC·Filed 2017·Granted Feb 26, 2019·2 cites·15 claims
- 1482US2023404954A1Modulators of the prostacyclin (pgi2) receptor useful for the treatment of disorders related theretoARENA PHARM INC·Filed 2023·Application pending·0 cites
- 1581USRE50267EModulators of the prostacyclin (PGI2) receptor useful for the treatment of disorders related theretoARENA PHARM INC·Filed 2022·Granted Jan 14, 2025·0 cites·35 claims
- 1679US2023121825A1Modulators of the prostacyclin (pgi2) receptor useful for the treatment of disorders related theretoARENA PHARM INC·Filed 2022·Application pending·0 cites
- 1777US10793529B2Substituted pyridazines and 1,2,4-triazines as prostacyclin receptor modulatorsARENA PHARM INC·Filed 2018·Granted Oct 6, 2020·1 cites·19 claims
- 1877US9987252B2Primary amines and derivitves thereof as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related theretoARENA PHARM INC·Filed 2016·Granted Jun 5, 2018·1 cites·15 claims
- 1974US10138210B2Substituted pyridazines as prostacyclin receptor modulatorsARENA PHARM INC·Filed 2016·Granted Nov 27, 2018·1 cites·33 claims
- 2071US2011224262A1Pyrazolyl substituted carbonic acid derivatives as modulators of the prostacyclin (pgi2) receptor useful for the treatment of disorders related theretoARENA PHARM INC·Filed 2009·Application pending·0 cites
- 2169US2020385357A1Substituted pyridazines and 1,2,4-triazines as prostacyclin receptor modulatorsARENA PHARM INC·Filed 2020·Application pending·0 cites
- 2269US2020375930A1Modulators of the prostacyclin (pgi2) receptor useful for the treatment of disorders related theretoARENA PHARM INC·Filed 2020·Application pending·0 cites
- 2365US2019070149A1Primary amines and derivatives thereof as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related theretoARENA PHARM INC·Filed 2018·Application pending·0 cites
- 2463US2015126527A1Modulators of the prostacyclin (pgi2) receptor useful for the treatment of disorders related theretoTRAN THUY-ANH·Filed 2014·Application pending·0 cites
- 2561US2015191454A1Modulators of the prostacyclin (pgi2) receptor useful for the treatment of disorders related theretoTRAN THUY-ANH·Filed 2014·Application pending·0 cites
- 2659US2013217706A1Modulators of the prostacyclin (pgi2) receptor useful for the treatment of disorders related theretoTRAN THUY-ANH·Filed 2012·Application pending·0 cites
- 2756US2020289659A1Conjugates for treating diseasesENDOCYTE INC·Filed 2020·Application pending·0 cites
- 2856US2015265576A1Primary amines and derivatives thereof as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related theretoARENA PHARM INC·Filed 2015·Application pending·0 cites
- 2952US2020323991A1Pbd conjugates for treating diseasesENDOCYTE INC·Filed 2017·Application pending·0 cites
- 3048US2021079039A1Compositions and methods for the selective delivery of therapeutic and imaging agentsAVELAS BIOSCIENCES INC·Filed 2019·Application pending·0 cites
- 3145US2020038514A1Folate conjugate for use in targeting tumor associated macrophagesENDOCYTE INC·Filed 2017·Application pending·0 cites
- 3244US2022347306A1Selective delivery of therapeutic and imaging agentsAVELAS BIOSCIENCES INC·Filed 2019·Application pending·0 cites
- 3343US2015152187A1Anti-PSMA Antibodies Conjugated to Nuclear Receptor Ligand PolypeptidesAMBRX INC·Filed 2013·Application pending·0 cites
- 3441US2005197350A1Novel quinoline, tetrahydroquinazoline, and pyrimidine derivatives and methods of treatment related to the use thereofARENA PHARM INC·Filed 2004·Application pending·0 cites
- 3540US2014309192A1Modulators of the g protein-coupled mas receptor and the treatment of disorders related theretoARENA PHARM INC·Filed 2012·Application pending·0 cites
- 3638US10624972B2Conjugates for treating diseasesENDOCYTE INC·Filed 2015·Granted Apr 21, 2020·0 cites·25 claims
Join the waitlist — get patent alerts
Get an alert when Ning Zou files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →